People: Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

22 Jul 2014
Price Change (% chg)

€0.10 (+1.20%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Jenkins, William 

Brief Biography

Dr. William J. Jenkins, M.D., serves as Independent Member of the Board of Directors of Ablynx NV. He is Principal of William Jenkins Pharma Consulting and has been advising a range of pharmaceutical and biotech companies, and investment and venture capital firms in the healthcare sector since 1999. Formerly, he was Head of Worldwide Clinical and Regulatory Affairs for Novartis Pharma and held a similar position with Glaxo Group Research Limited. He is currently Senior Independent Director of Consort Medical, an ad hoc Member of the Board of Evotec and a Member of the Advisory Board of Chiesi Farmaceutici. In addition, he serves as Chairman of the Scientific Advisory Board of Evotec and is a Member of the Scientific Advisory Boards of BB Biotech Ventures II and III funds, and until recently Nicholas Piramal India. He received a Doctorate of Medicine degree from the University of Cambridge and a Master of Arts degree from the University of Cambridge.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks